Despite undoubted advances in medicine, the reality is that around 40% of the population will suffer from chronic diseases, including degenerative or autoimmune diseases, for which there is no cure. Growing scientific knowledge highlights the great complexity of the mechanisms of these diseases. Attempting to solve them by means of classical drugs, which consist of molecules that act on a very limited number of therapeutic targets, is clearly insufficient.
We have to add the problem of the progressive ageing of the population, which is experiencing an increase in physiological vulnerability. The consequences include a significant increase in chronic degenerative diseases, an increased susceptibility to serious infections, the risk of drug interactions and adverse effects due to drug combinations, and ultimately a reduced quality of life.
